Connect with a research-ready network spanning 30M+ patients, 200 research sites, and 1000+ trials to accelerate feasibility, sharpen site selection, and generate deeper evidence across the clinical development lifecycle.
See how our AI-powered platform analyzes structured and unstructured EHR data to surface the right sites and patients faster than manual process.
Site Networks
Access AI-powered technology and a connected research network that help sites strengthen trial readiness, expand sponsor relationships, and unlock more value from their clinical data.
Connect your sites to a research network that attracts sponsors, increases study volume, and turns your clinical data into a long-term competitive advantage.
Smarter Site Selection: What Sites Can Do to Stand Out in Feasibility Scoring Sponsors are no longer relying solely on surveys and gut instinct to select clinical trial sites. Increasingly, they’re turning to site feasibility scoring tools that use real-time data to...
The Hidden Cost of Protocol Deviation and How Better Patient Matching Solves It Protocol deviations are one of the most persistent and costly challenges in clinical research. For sites, they increase workload, trigger regulatory scrutiny, and often reflect systemic...
What If You Could Skip the Manual Chart Review? AI Tools Built for CRCs Clinical research coordinators (CRCs) are the unsung heroes of clinical trials. They manage the chaos, keep protocols on track, and quietly spend hours buried in electronic medical records (EMRs)...
From Static Lists to Real-Time Matches: How AI Is Revolutionizing Trial Eligibility Screening In clinical research, timing isn’t just important—it’s everything. Yet many sites and sponsors still rely on outdated recruitment methods like static prescreening lists,...
Safeguarding Patient Trust: Ethics and Privacy in Real‑World Data AI Real-world data (RWD) is transforming clinical research. From accelerating feasibility assessments to identifying hard-to-reach patients, RWD powers the next generation of AI-enabled innovation. But...
